Identification and management of oral isotretinoin use inconsistent with product labeling

Managed Care Interface

Volumn 16, Issue 3, 2003, Pages 41-43+55

  Wert, Scott ^a  

^a Health Net Pharmaceutical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; MINOCYCLINE; RETINOIC ACID; RETINOID; TAZAROTENE; TETRACYCLINE DERIVATIVE;

ACNE; ADOLESCENT; ADULT; ARTICLE; DATA BASE; DRUG INDICATION; DRUG LABELING; DRUG UTILIZATION; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; SCHOOL CHILD; SIDE EFFECT;

ABNORMALITIES, DRUG-INDUCED; ACNE VULGARIS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ARIZONA; CLINICAL PHARMACY INFORMATION SYSTEMS; DRUG LABELING; DRUG UTILIZATION REVIEW; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES RESEARCH; HUMANS; ISOTRETINOIN; MALE; PATIENT COMPLIANCE; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 0037350302     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Isotretinion prescribing information. Nutley, NJ, Roche Laboratories, Inc., 2001.
2. Meigel WN: How safe is oral isotretinoin? Dermatology 1997; 195(suppl 1):22-28,38-40.
3. Scheinman PL, Peck GL, Rubinow DR, et al: Acute depression from isotretinoin. J Am Acad Dermatol 1990;22:1112-1114.
4. Jick SS, Kremers HM, Vasilakis-Scaramozza C: Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000;136:1211-1216.
5. Wysowski DK: Methodological limitations of the study "Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide." Arch Dermatol 2001;137:1102-1103.
6. House Accutane safety hearing will include testimony from FDA's Woodcock. Pink Sheet 2000;62(49):9.
7. Perlman SE, Leach EE, Dominguez L, et al: "Be smart, be safe, be sure": The revised Pregnancy Prevention Program for women on isotretinoin. J Reprod Med 2001;46(suppl 2):179-185.
8. Physician Drug and Diagnosis Audit, January 1996-December 2000. Newtown, PA, Scott-Levin, Inc., 2001.
9. Accutane-exposed pregnancies - California, 1999. MMWR 2000;49:28-31.
10. Honein MA, Paulozzi LJ, Erickson JD: Continued occurrence of Accutane-exposed pregnancies. Teratology 2001;64:142-147.